Lowered valproate doses during pregnancy may curb birth defect risks

Prenatal exposure to valproate was linked to increased odds of babies developing spina bifida and hypospadias, but researchers found that lowering the dose of the medication in the first trimester could control women's epileptic seizures without raising their child's risk of having the defects. The findings appear in the journal American Academy of Neurology.

View Full Article in:

Herald Sun (Melbourne, Australia) (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA